Patent · US Active

Epidermal growth factor receptor variants and pharmaceutical compositions thereof

US8703917B2 · kind B2 · utility

2Cited by

1References

3Claims

0Family size

Assignee

SHANGHAI CANCER INSTITUTE · CN

Inventors

Zonghai LI · Shanghai, CN
Hai Wang · San Diego, US
Min Zhou · Suzhou, CN
Xiaorong Pan · Shanghai, CN
Jianren Gu · Shanghai, CN
Shengli Yang · 安丰镇, CN

Key dates

Filing date	Jan 26, 2011
Grant date	Apr 22, 2014
Priority date	—
Expiry date	Jan 26, 2031

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/71
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Provided are a novel Epidermal growth factor receptor variant-EGFRvA protein, a polynucleotide encoding the EGFRvA protein and a method of preparing the EGFRvA protein via recombination technology. Also provided is a uses of the polynucleotide encoding the EGFRvA protein. The EGFRvA protein has a function of promoting tumor cell invasion or promoting tumor cell migration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.